Regeneron stock: Management schedules healthcare conferences
Published on 11/04/2026 at 17:34 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSFresh investor dates for Regeneron
- Management will present at healthcare conferences hosted by Jefferies, Evercore and Citi.
- Regeneron says it has nearly 50 candidates in development and 16 medicines developed in-house have been approved.
- The events may give investors further insight into the company's pipeline and development priorities.
Regeneron Pharmaceuticals will webcast management presentations at three healthcare investor conferences in November and December. The company announced the schedule on November 2 in a Regeneron Pharmaceuticals investor release.
Management puts dates on calendar
Regeneron will take part in the Jefferies Global Healthcare Conference in London on Tuesday, November 17, at 2:00 p.m. GMT, or 9:00 a.m. Eastern Time. The company is also scheduled for the Evercore Healthcare Conference on Tuesday, December 1, at 1:45 p.m. Eastern Time, followed by Citi's Global Healthcare Conference on Wednesday, December 2, at 9:40 a.m. Eastern Time.
Regeneron said the sessions will be available through its investor website. Replays and transcripts are expected to remain available for at least 30 days, giving investors access to management commentary after each event.
Pipeline remains central
Regeneron's corporate website highlights nearly 50 candidates in development and 16 approved medicines developed in-house. The scheduled appearances therefore give investors additional points at which management can discuss research priorities, clinical progress and the commercial outlook for its medicines.
Current trading context
Regeneron stock traded at 853.70 euros on Lang & Schwarz at 17:32 CET on Wednesday, November 4, 2026. The real-time quote of Regeneron stock is available on the company snapshot page.
Regeneron Pharmaceuticals at a glance
- Company: Regeneron Pharmaceuticals, Inc.
- ISIN: US75886F1075
- Ticker: REGN
- Home exchange: Nasdaq
- Lang & Schwarz quote: 853.70 euros at 17:32 CET on November 4, 2026
Regeneron's US market setting can be followed through the S&P 500 market topic.
